Global Neuro-Oncological Diseases Device Market Research Report 2021

1 Neuro-Oncological Diseases Device Market Overview
1.1 Product Overview and Scope of Neuro-Oncological Diseases Device
1.2 Neuro-Oncological Diseases Device Segment by Type
1.2.1 Global Neuro-Oncological Diseases Device Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 MRI
1.2.3 CT Scan
1.2.4 PET
1.2.5 Others
1.3 Neuro-Oncological Diseases Device Segment by Application
1.3.1 Neuro-Oncological Diseases Device Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Centers
1.3.5 Reference Laboratories
1.3.6 Medical Research Institutes
1.3.7 Others
1.4 Global Neuro-Oncological Diseases Device Market Size Estimates and Forecasts
1.4.1 Global Neuro-Oncological Diseases Device Revenue 2016-2027
1.4.2 Global Neuro-Oncological Diseases Device Sales 2016-2027
1.4.3 Neuro-Oncological Diseases Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neuro-Oncological Diseases Device Market Competition by Manufacturers
2.1 Global Neuro-Oncological Diseases Device Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neuro-Oncological Diseases Device Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neuro-Oncological Diseases Device Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neuro-Oncological Diseases Device Manufacturing Sites, Area Served, Product Type
2.5 Neuro-Oncological Diseases Device Market Competitive Situation and Trends
2.5.1 Neuro-Oncological Diseases Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neuro-Oncological Diseases Device Players Market Share by Revenue
2.5.3 Global Neuro-Oncological Diseases Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neuro-Oncological Diseases Device Retrospective Market Scenario by Region
3.1 Global Neuro-Oncological Diseases Device Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Neuro-Oncological Diseases Device Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.3.1 North America Neuro-Oncological Diseases Device Sales by Country
3.3.2 North America Neuro-Oncological Diseases Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.4.1 Europe Neuro-Oncological Diseases Device Sales by Country
3.4.2 Europe Neuro-Oncological Diseases Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neuro-Oncological Diseases Device Market Facts & Figures by Region
3.5.1 Asia Pacific Neuro-Oncological Diseases Device Sales by Region
3.5.2 Asia Pacific Neuro-Oncological Diseases Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.6.1 Latin America Neuro-Oncological Diseases Device Sales by Country
3.6.2 Latin America Neuro-Oncological Diseases Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Neuro-Oncological Diseases Device Sales by Country
3.7.2 Middle East and Africa Neuro-Oncological Diseases Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Neuro-Oncological Diseases Device Historic Market Analysis by Type
4.1 Global Neuro-Oncological Diseases Device Sales Market Share by Type (2016-2021)
4.2 Global Neuro-Oncological Diseases Device Revenue Market Share by Type (2016-2021)
4.3 Global Neuro-Oncological Diseases Device Price by Type (2016-2021)

5 Global Neuro-Oncological Diseases Device Historic Market Analysis by Application
5.1 Global Neuro-Oncological Diseases Device Sales Market Share by Application (2016-2021)
5.2 Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2016-2021)
5.3 Global Neuro-Oncological Diseases Device Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Siemens Healthcare
6.1.1 Siemens Healthcare Corporation Information
6.1.2 Siemens Healthcare Description and Business Overview
6.1.3 Siemens Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Siemens Healthcare Product Portfolio
6.1.5 Siemens Healthcare Recent Developments/Updates
6.2 Philips Healthcare
6.2.1 Philips Healthcare Corporation Information
6.2.2 Philips Healthcare Description and Business Overview
6.2.3 Philips Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Philips Healthcare Product Portfolio
6.2.5 Philips Healthcare Recent Developments/Updates
6.3 Canon Medical Systems
6.3.1 Canon Medical Systems Corporation Information
6.3.2 Canon Medical Systems Description and Business Overview
6.3.3 Canon Medical Systems Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Canon Medical Systems Product Portfolio
6.3.5 Canon Medical Systems Recent Developments/Updates
6.4 GE Healthcare
6.4.1 GE Healthcare Corporation Information
6.4.2 GE Healthcare Description and Business Overview
6.4.3 GE Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GE Healthcare Product Portfolio
6.4.5 GE Healthcare Recent Developments/Updates
6.5 Hitachi Medical
6.5.1 Hitachi Medical Corporation Information
6.5.2 Hitachi Medical Description and Business Overview
6.5.3 Hitachi Medical Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hitachi Medical Product Portfolio
6.5.5 Hitachi Medical Recent Developments/Updates

7 Neuro-Oncological Diseases Device Manufacturing Cost Analysis
7.1 Neuro-Oncological Diseases Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neuro-Oncological Diseases Device
7.4 Neuro-Oncological Diseases Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neuro-Oncological Diseases Device Distributors List
8.3 Neuro-Oncological Diseases Device Customers

9 Neuro-Oncological Diseases Device Market Dynamics
9.1 Neuro-Oncological Diseases Device Industry Trends
9.2 Neuro-Oncological Diseases Device Growth Drivers
9.3 Neuro-Oncological Diseases Device Market Challenges
9.4 Neuro-Oncological Diseases Device Market Restraints

10 Global Market Forecast
10.1 Neuro-Oncological Diseases Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neuro-Oncological Diseases Device by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neuro-Oncological Diseases Device by Type (2022-2027)
10.2 Neuro-Oncological Diseases Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neuro-Oncological Diseases Device by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neuro-Oncological Diseases Device by Application (2022-2027)
10.3 Neuro-Oncological Diseases Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neuro-Oncological Diseases Device by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neuro-Oncological Diseases Device by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Neuro-Oncological Diseases Device Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Neuro-Oncological Diseases Device Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Neuro-Oncological Diseases Device Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Neuro-Oncological Diseases Device Covered in This Study
Table 5. Global Neuro-Oncological Diseases Device Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Neuro-Oncological Diseases Device Sales Share by Manufacturers (2016-2021)
Table 7. Global Neuro-Oncological Diseases Device Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Neuro-Oncological Diseases Device Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Neuro-Oncological Diseases Device Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Neuro-Oncological Diseases Device Manufacturing Sites and Area Served
Table 11. Manufacturers Neuro-Oncological Diseases Device Product Type
Table 12. Global Neuro-Oncological Diseases Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neuro-Oncological Diseases Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuro-Oncological Diseases Device as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neuro-Oncological Diseases Device Sales by Region (2016-2021) & (Units)
Table 16. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2016-2021)
Table 17. Global Neuro-Oncological Diseases Device Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Neuro-Oncological Diseases Device Sales by Country (2016-2021) & (Units)
Table 19. North America Neuro-Oncological Diseases Device Sales Market Share by Country (2016-2021)
Table 20. North America Neuro-Oncological Diseases Device Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Neuro-Oncological Diseases Device Revenue Market Share by Country (2016-2021)
Table 22. Europe Neuro-Oncological Diseases Device Sales by Country (2016-2021) & (Units)
Table 23. Europe Neuro-Oncological Diseases Device Sales Market Share by Country (2016-2021)
Table 24. Europe Neuro-Oncological Diseases Device Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Neuro-Oncological Diseases Device Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Neuro-Oncological Diseases Device Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Neuro-Oncological Diseases Device Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Neuro-Oncological Diseases Device Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Neuro-Oncological Diseases Device Revenue Market Share by Region (2016-2021)
Table 30. Latin America Neuro-Oncological Diseases Device Sales by Country (2016-2021) & (Units)
Table 31. Latin America Neuro-Oncological Diseases Device Sales Market Share by Country (2016-2021)
Table 32. Latin America Neuro-Oncological Diseases Device Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Neuro-Oncological Diseases Device Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Neuro-Oncological Diseases Device Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Neuro-Oncological Diseases Device Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Neuro-Oncological Diseases Device Revenue Market Share by Country (2016-2021)
Table 38. Global Neuro-Oncological Diseases Device Sales (Units) by Type (2016-2021)
Table 39. Global Neuro-Oncological Diseases Device Sales Market Share by Type (2016-2021)
Table 40. Global Neuro-Oncological Diseases Device Revenue (Million US$) by Type (2016-2021)
Table 41. Global Neuro-Oncological Diseases Device Revenue Share by Type (2016-2021)
Table 42. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Type (2016-2021)
Table 43. Global Neuro-Oncological Diseases Device Sales (Units) by Application (2016-2021)
Table 44. Global Neuro-Oncological Diseases Device Sales Market Share by Application (2016-2021)
Table 45. Global Neuro-Oncological Diseases Device Revenue (Million US$) by Application (2016-2021)
Table 46. Global Neuro-Oncological Diseases Device Revenue Share by Application (2016-2021)
Table 47. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Application (2016-2021)
Table 48. Siemens Healthcare Corporation Information
Table 49. Siemens Healthcare Description and Business Overview
Table 50. Siemens Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Siemens Healthcare Neuro-Oncological Diseases Device Product
Table 52. Siemens Healthcare Recent Developments/Updates
Table 53. Philips Healthcare Corporation Information
Table 54. Philips Healthcare Description and Business Overview
Table 55. Philips Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Philips Healthcare Neuro-Oncological Diseases Device Product
Table 57. Philips Healthcare Recent Developments/Updates
Table 58. Canon Medical Systems Corporation Information
Table 59. Canon Medical Systems Description and Business Overview
Table 60. Canon Medical Systems Neuro-Oncological Diseases Device Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Canon Medical Systems Neuro-Oncological Diseases Device Product
Table 62. Canon Medical Systems Recent Developments/Updates
Table 63. GE Healthcare Corporation Information
Table 64. GE Healthcare Description and Business Overview
Table 65. GE Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. GE Healthcare Neuro-Oncological Diseases Device Product
Table 67. GE Healthcare Recent Developments/Updates
Table 68. Hitachi Medical Corporation Information
Table 69. Hitachi Medical Description and Business Overview
Table 70. Hitachi Medical Neuro-Oncological Diseases Device Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Hitachi Medical Neuro-Oncological Diseases Device Product
Table 72. Hitachi Medical Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Neuro-Oncological Diseases Device Distributors List
Table 76. Neuro-Oncological Diseases Device Customers List
Table 77. Neuro-Oncological Diseases Device Market Trends
Table 78. Neuro-Oncological Diseases Device Growth Drivers
Table 79. Neuro-Oncological Diseases Device Market Restraints
Table 80. Global Neuro-Oncological Diseases Device Sales Forecast by Type (2022-2027) & (Units)
Table 81. Global Neuro-Oncological Diseases Device Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Neuro-Oncological Diseases Device Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Neuro-Oncological Diseases Device Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Neuro-Oncological Diseases Device Sales Forecast by Application (2022-2027) & (Units)
Table 85. Global Neuro-Oncological Diseases Device Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Neuro-Oncological Diseases Device Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Neuro-Oncological Diseases Device Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Neuro-Oncological Diseases Device Sales Forecast by Region (2022-2027) & (Units)
Table 89. Global Neuro-Oncological Diseases Device Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Neuro-Oncological Diseases Device Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Neuro-Oncological Diseases Device Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuro-Oncological Diseases Device
Figure 2. Global Neuro-Oncological Diseases Device Market Share by Type in 2020 & 2027
Figure 3. MRI Product Picture
Figure 4. CT Scan Product Picture
Figure 5. PET Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neuro-Oncological Diseases Device Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Diagnostics Centers
Figure 11. Reference Laboratories
Figure 12. Medical Research Institutes
Figure 13. Others
Figure 14. Global Neuro-Oncological Diseases Device Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Neuro-Oncological Diseases Device Market Size 2016-2027 (US$ Million)
Figure 16. Global Neuro-Oncological Diseases Device Sales 2016-2027 (Units)
Figure 17. Global Neuro-Oncological Diseases Device Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Neuro-Oncological Diseases Device Sales Share by Manufacturers in 2020
Figure 19. Global Neuro-Oncological Diseases Device Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Neuro-Oncological Diseases Device Players: Market Share by Revenue in 2020
Figure 21. Neuro-Oncological Diseases Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2016-2021)
Figure 23. Global Neuro-Oncological Diseases Device Sales Market Share by Region in 2020
Figure 24. Global Neuro-Oncological Diseases Device Revenue Market Share by Region (2016-2021)
Figure 25. Global Neuro-Oncological Diseases Device Revenue Market Share by Region in 2020
Figure 26. U.S. Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Neuro-Oncological Diseases Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Neuro-Oncological Diseases Device by Type (2016-2021)
Figure 51. Sales Market Share of Neuro-Oncological Diseases Device by Application (2016-2021)
Figure 52. Sales Market Share of Neuro-Oncological Diseases Device by Application in 2020
Figure 53. Revenue Share of Neuro-Oncological Diseases Device by Application (2016-2021)
Figure 54. Revenue Share of Neuro-Oncological Diseases Device by Application in 2020
Figure 55. Manufacturing Cost Structure of Neuro-Oncological Diseases Device
Figure 56. Manufacturing Process Analysis of Neuro-Oncological Diseases Device
Figure 57. Neuro-Oncological Diseases Device Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.